About

Who we are

PIRC helps bring new hope to patients with hematologic diseases, with drug discovery that drives PharmaEssentia’s best-in-class therapies.

As an integral part of PharmaEssentia’s global R&D team, we have the strength of the global enterprise behind us as we accelerate priority development programs across oncology, hematology, and immunology. As PharmaEssentia’s first U.S.-based research center, we are expanding the company’s global presence, establishing an innovation bridge that connects Taiwan and Boston.

Leadership

Lih-Ling Lin, Ph.D.

Chief Scientific Officer

  • Ph.D., Biochemistry, University of Arizona
  • Cluster Head, Checkpoint Immunology, Immunology and Inflammation Research, Sanofi
  • Senior Director in Innate Immunity and Inflammation, Pfizer

Tom Lin

Senior Director of Operations and Data Science

  • M.A., Harvard University
  • M.S. candidate, Bioinformatics, Johns Hopkins University
  • Senior Data Analyst and Senior IT Systems Analyst in government and consulting
  • 15 years of experience in data analysis, data visualization, and web application development

Kuan-Chun Huang, Ph.D

Senior Director of Pharmacology and Translational Science

  • Ph.D., Molecular Virology, Immunology, and Medical Genetics, Ohio State University
  • Post-doctoral Fellow, Brigham and Women’s Hospital
  • Director, Immuno-oncology and Pharmacology, H3 Biomedicine
  • Principal Scientist, Immuno-Oncology, Eisai, Inc.

Ming-Tang Chen, Ph.D.

Senior Director of Biologics Platform

  • Ph.D., Synthetic Biology, Princeton University
  • M.A., Electrical and Computer Engineering, Princeton University
  • Principal Scientist, Discovery Biologics In Vitro Display Group and Biologics
  • Engineering and Expression Group, Merck

Lei Shang, Ph.D.

Director, AI in Drug Development

  • Ph.D., Bioinformatics & Computational Biology, University of Texas at Austin
  • M.S., Bioinformatics, Zhejiang University
  • B.S., Biological Science, Zhejiang University
  • Director, Duality Biologics
  • Senior Manager, Pfizer
  • Senior Staff Engineer, Qiagen
  • Staff Engineer, Qiagen
  • Associate Staff Engineer, Qiagen
  • Bioinformatics Scientist, Qiagen
  • Bioinformatics Specialist, The Rockefeller University

Erik Sampson, Ph.D.

Director of Translational Pharmacology

  • Ph.D., Genetics, Genomics and Disease, University of Rochester
  • M.A., Pathology and Molecular Medicine, University of Rochester
  • Associate Director, Immuno-Oncology, Rome Therapeutics
  • Senior Principal Scientist, Immunology, Pandion Therapeutics
  • Senior Scientist, Immunology Discovery, Abbott Laboratories/AbbVie

Priscilla Lee, Ph.D.

Associate Director, Portfolio/Project Management

  • Ph.D., Biomedical Science, Ohio State University
  • M.S., Immunology, National Taiwan University College of Medicine
  • B.S., Life Science, National Taiwan University
  • Associate, RA Ventures
  • Associate, RA Capital Management
  • Scientist/Senior Scientist, I&I TA, Sanofi
  • Post-Doctoral Fellow, I&I RU, Pfizer
  • Post-Doctoral Researcher, Graduate Research Fellow, The Ohio State University

Careers at PIRC

PIRC is growing fast. We are actively seeking scientists, associates, and other professionals with drug discovery experience who are excited about doing cutting-edge science that provides doctors with new tools for treating rare cancers and autoimmune conditions.